Insider · CIK 0001277161
SIDRANSKY DAVID
Reports to the SEC for 12 companies · ROCKVILLE, MD
Transactions
50
Companies
12
Filings
13
CIK
0001277161
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2025-11-05 | CSBRCHAMPIONS ONCOLOGY, INC. · Option to purchase Common StockA Award | +$144K |
| 2024-11-12 | CSBRCHAMPIONS ONCOLOGY, INC. · Option to purchase Common StockA Award | +$102K |
| 2023-12-20 | Orgenesis Inc.Stock OptionA Award | — |
| 2023-11-03 | CSBRCHAMPIONS ONCOLOGY, INC. · Option to purchase Common StockA Award | +$85.4K |
| 2023-01-19 | Ayala Pharmaceuticals, Inc.Stock OptionA Award | — |
| 2023-01-19 | Old Ayala, IncStock Option (right to buy)D Disposition to Issuer | — |
| 2023-01-19 | Ayala Pharmaceuticals, Inc.A Award | — |
| 2023-01-19 | Old Ayala, IncStock Option (right to buy)D Disposition to Issuer | — |
| 2023-01-19 | Old Ayala, IncD Disposition to Issuer | — |
| 2023-01-19 | Ayala Pharmaceuticals, Inc.Stock OptionA Award | — |
| 2022-12-23 | Orgenesis Inc.Stock OptionA Award | — |
| 2022-11-01 | CSBRCHAMPIONS ONCOLOGY, INC. · Option to purchase Common StockA Award | +$80.4K |
| 2022-10-12 | CSBRCHAMPIONS ONCOLOGY, INC. · Option to purchase Common StockM Exercise/Conversion | — |
| 2022-10-12 | CSBRCHAMPIONS ONCOLOGY, INC.F Tax Payment | −$26.8K |
| 2022-10-12 | CSBRCHAMPIONS ONCOLOGY, INC.M Exercise/Conversion | +$26.7K |
| 2022-06-13 | Old Ayala, IncStock Option (Right to Buy)A Award | — |
| 2021-12-16 | Orgenesis Inc.Stock Option (Right to Buy)A Award | — |
| 2021-11-05 | CSBRCHAMPIONS ONCOLOGY, INC. · Option to purchase Common StockA Award | +$81.3K |
| 2021-10-15 | CSBRCHAMPIONS ONCOLOGY, INC. · Option to purchase Common StockA Award | — |
| 2021-10-15 | CSBRCHAMPIONS ONCOLOGY, INC.F Tax Payment | +$26.5K |
| 2021-10-15 | CSBRCHAMPIONS ONCOLOGY, INC.M Exercise/Conversion | +$26.5K |
| 2021-06-10 | Old Ayala, IncStock Option (Right to Buy)A Award | — |
| 2020-12-23 | Old Ayala, IncP Purchase | +$46.24 |
| 2020-12-08 | CSBRCHAMPIONS ONCOLOGY, INC. · Option to purchase Common StockA Award | +$99.7K |
| 2020-10-16 | CSBRCHAMPIONS ONCOLOGY, INC.F Tax Payment | −$91K |
| 2020-10-16 | CSBRCHAMPIONS ONCOLOGY, INC.M Exercise/Conversion | +$91K |
| 2020-10-16 | CSBRCHAMPIONS ONCOLOGY, INC. · Option to purchase Common StockM Exercise/Conversion | — |
| 2020-09-14 | Old Ayala, IncP Purchase | +$10.7 |
| 2020-09-11 | Old Ayala, IncP Purchase | +$100.7 |
| 2020-08-14 | Old Ayala, IncP Purchase | +$55.35 |
| 2020-07-17 | Old Ayala, IncP Purchase | +$47.44 |
| 2020-07-07 | Old Ayala, IncP Purchase | +$9.6 |
| 2020-05-20 | Orgenesis Inc.P Purchase | +$69.8 |
| 2020-05-13 | Orgenesis Inc.P Purchase | +$417.2 |
| 2020-05-12 | Orgenesis Inc.P Purchase | +$531 |
| 2020-05-12 | Old Ayala, IncP Purchase | +$375.5 |
| 2020-05-08 | Old Ayala, IncP Purchase | +$3,054 |
| 2020-05-07 | Orgenesis Inc.P Purchase | +$54.2 |
| 2020-05-04 | Ayala Pharmaceuticals, Inc.OptionA Award | — |
| 2020-03-19 | Orgenesis Inc.Stock OptionA Award | — |
| 2019-12-17 | Orgenesis Inc.Stock OptionA Award | — |
| 2019-11-04 | CSBRCHAMPIONS ONCOLOGY, INC. · Option to purchase Common StockA Award | +$45.2K |
| 2019-10-24 | Ayala Pharmaceuticals, Inc.OptionA Award | — |
| 2018-11-05 | Ayala Pharmaceuticals, Inc.OptionA Award | — |
| 2018-11-01 | CSBRCHAMPIONS ONCOLOGY, INC. · Option to purchase Common StockA Award | +$106K |
| 2018-10-22 | Orgenesis Inc.Stock OptionA Award | — |
| 2018-10-22 | Orgenesis Inc.Stock OptionA Award | — |
| 2018-06-26 | Ayala Pharmaceuticals, Inc.A Award | — |
| 2018-06-13 | Ayala Pharmaceuticals, Inc.A Award | +$8,550 |
| 2018-06-12 | Ayala Pharmaceuticals, Inc.A Award | +$12.5K |
Recent filings
- 4SIDRANSKY DAVID0001628280-25-050514SEC(opens sec.gov)
- 4SIDRANSKY DAVID0001628280-24-048211SEC(opens sec.gov)
- 4SIDRANSKY DAVID0001493152-23-045777SEC(opens sec.gov)
- 4SIDRANSKY DAVID0001628280-23-037248SEC(opens sec.gov)
- 4SIDRANSKY DAVID0001628280-23-029776SEC(opens sec.gov)
- 4SIDRANSKY DAVID0001213900-23-004541SEC(opens sec.gov)
- 4SIDRANSKY DAVID0001493152-23-002246SEC(opens sec.gov)
- 4SIDRANSKY DAVID0001493152-22-036752SEC(opens sec.gov)
- 4SIDRANSKY DAVID0001628280-22-026400SEC(opens sec.gov)
- 4SIDRANSKY DAVID0000899243-22-022562SEC(opens sec.gov)
- 5SIDRANSKY DAVID0001493152-22-004492SEC(opens sec.gov)
- 4SIDRANSKY DAVID0001628280-21-022608SEC(opens sec.gov)
- 4SIDRANSKY DAVID0001628280-21-020221SEC(opens sec.gov)
Companies
- Akari Therapeutics PlcDirectorAKTX
- ASCENTAGE PHARMA GROUP INTERNATIONALDirectorAAPG
- Ayala Pharmaceuticals, Inc.Director
- Cactus Acquisition Corp. 1 LtdDirector
- CHAMPIONS ONCOLOGY, INC.DirectorCSBR
- Galmed Pharmaceuticals Ltd.DirectorGLMD
- IMCLONE SYSTEMS INCDirector, VICE CHAIRMAN OF THE BOARD
- IMMUNE PHARMACEUTICALS INCDirector
- K-V Pharmaceutical CoDirector
- Old Ayala, IncDirector
- Orgenesis Inc.Director
- TAMIR BIOTECHNOLOGY, INC.Director
Address
700 KING FARM BLVD STE 510
ROCKVILLE, MD, 20850